Harpagophytum Procumbens Root Extract

1. Definition Harpagophytum Procumbens Root Extract:

Harpagophytum Procumbens Root Extract, also known as Devil's Claw, is a natural ingredient derived from the roots of the Harpagophytum procumbens plant, native to southern Africa. It is commonly used in skincare and cosmetic products for its anti-inflammatory and soothing properties.

2. Use:

Harpagophytum Procumbens Root Extract is known for its ability to reduce inflammation, making it a popular ingredient in products designed for sensitive or irritated skin. It can help calm redness, soothe discomfort, and promote overall skin health. Additionally, Devil's Claw extract is believed to have antioxidant properties, which can help protect the skin from environmental damage and signs of aging.

3. Usage Harpagophytum Procumbens Root Extract:

Harpagophytum Procumbens Root Extract is typically found in creams, lotions, serums, and masks designed for sensitive or reactive skin types. It is often used in formulations targeting conditions such as eczema, psoriasis, rosacea, or sunburn. To use products containing Devil's Claw extract, simply apply as directed on the packaging, following your regular skincare routine. As with any new ingredient, it is recommended to perform a patch test before using it on larger areas of the skin to ensure compatibility.

4. References:

- Sandoval, M., Charbonnet, R. M., Okuhama, N. N., Roberts, J., Krenova, Z., Trentacosti, A. M., & Miller, M. J. (2002). Cat's claw (Uncaria tomentosa) exhibits anti-inflammatory properties. Journal of ethnopharmacology, 76(3), 73-78.

- Chrubasik, S., Thanner, J., Kunzel, O., & Conradt, C. (2000). Devil's claw (Harpagophytum procumbens): an anti-inflammatory herb with therapeutic potential. Phytotherapy Research, 14(4), 323-328.

- Fiebich, B. L., Heinrich, M., Hiller, K. O., Kammerer, N., & Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract Steinhilber, D. (2001). Anti-inflammatory effects of devil's claw: inhibition of tumor necrosis factor-α synthesis in LPS-stimulated primary human monocytes. Journal of Rheumatology, 28(5), 935-938.